Coronavirus News and Research

RSS

Scientists develop human lung organoids to study SARS-CoV-2 infection

Now, a new study published on the preprint server bioRxiv in July 2020 reports the development of a human distal lung culture system that can be functionally tested. This will help not only to understand how this infection produces disease but also to test the proliferative capacity of the stem cells in this part of the body.

30 Jul 2020

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19

Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows.

30 Jul 2020

Study reports highly potent anti-SARS-CoV-2 compounds

A new study published on the preprint server bioRxiv in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary viral proteases.

30 Jul 2020

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to attack the human airway epithelium primarily. In severely affected patients, the illness progresses to hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). The latter is treatable mainly by supportive management.

30 Jul 2020

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.

30 Jul 2020

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

A new study published on the preprint server bioRxiv in July 2020 reports the discovery of some antibody molecules that have powerful enhancing or neutralizing activity against the virus, in a library of synthetic antibodies. These hold the promise of being useful for the prevention or treatment of this illness.

30 Jul 2020

COVID-19 pandemic is "one big wave" says WHO

The COVID-19 pandemic that has gripped the world has to date infected over 16.95 million individuals and taken more than 665,000 lives. Now the World Health Organisation (WHO) has warned that this pandemic could cause a Tsunami of cases, and there is no scope for complacency in regions where numbers have declined.

30 Jul 2020

Relatives of SARS-CoV-2 may pose a health threat for years to come

Coronaviruses are zoonotic viruses that jump from animals to humans and cause infection. There are many types of common human coronaviruses, which usually cause mild to moderate upper-respiratory tract illnesses, like the common cold. Most people get infected with one or more of coronavirus types 229E, NL63, OC43, and HKU1 at some point in their lives.

29 Jul 2020

The toll that COVID-19 takes on the heart

Now, two new studies describe the toll that COVID-19 takes in the heart, increasing the risk of long-term damage even after patients recover. These studies also show that heart damage can even occur in people who did not have severe illness that required hospitalization.

29 Jul 2020

Loss of smell in COVID-19 explained by scientists

Now, a team of researchers at Harvard Medical school says they have found the reason why some people who get COVID-19 experience loss of smell.

29 Jul 2020

COVID-19 could provide unintended glimpses into operation of complex Earth systems

Like the legendary falling apple that hit Isaac Newton and led to his groundbreaking insight on the nature of gravity, COVID-19 could provide unintended glimpses into how complex Earth systems operate, according to a new Stanford-led paper.

29 Jul 2020

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

29 Jul 2020

Unexpected neurologic complication identified in severe COVID-19

Physicians working at Cambridge University Hospital NHS Foundation Trust have reported that a significant proportion of patients with severe coronavirus disease 2019 (COVID-19) who required intensive care developed unanticipated disabling neurological deficits that were related to a mononeuritis multiplex.

29 Jul 2020

People with SARS-CoV-2 most infectious in days 0-5, no evidence of transmission after day 9

A study conducted by researchers in the UK and Italy suggests that individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are probably at their most infectious during the first week of illness.

29 Jul 2020

ONR helps develop low-cost ventilators to combat COVID-19

One of the most dangerous effects of coronavirus is the inability to breathe on your own--requiring the help of a ventilator to push air through your lungs.

29 Jul 2020

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

Black and Hispanic pregnant women in Philadelphia are five times as likely as white and Asian women to have been exposed to the novel coronavirus, according to a new study led by Scott Hensley, PhD, an associate professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, and Karen Marie Puopolo, MD, PhD, an associate professor of Pediatrics and neonatologist at the Children's Hospital of Philadelphia. The study was published today in Science Immunology.

29 Jul 2020

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

A study led by Charité - Universitätsmedizin Berlin and the Max Planck Institute for Molecular Genetics (MPIMG) shows that some healthy individuals possess immune cells capable of recognizing the novel coronavirus, SARS-CoV-2.

29 Jul 2020

BMC joins Aspen Institute initiative to improve families’ health and economic prosperity

Boston Medical Center's StreetCred program has been named to the second cohort of the Aspen Family Prosperity Innovation Community, an Aspen Institute initiative for breakthrough innovations and collaborations that position families to reach educational success, economic prosperity, and health and well-being.

29 Jul 2020

Non-White adults are more likely to worry about paying for COVID-19 treatment

People of color are far more likely to worry about their ability to pay for healthcare if diagnosed with COVID-19 than their White counterparts, according to a new survey from nonprofit West Health and Gallup.

29 Jul 2020

COVID-19 may increase risk of blot cots in women who are pregnant or taking birth control pills

COVID-19 may increase the risk of blot cots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.

29 Jul 2020

Coronavirus News and Research

Scientists develop human lung organoids to study SARS-CoV-2 infection

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19

Study reports highly potent anti-SARS-CoV-2 compounds

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

COVID-19 pandemic is "one big wave" says WHO

Relatives of SARS-CoV-2 may pose a health threat for years to come

The toll that COVID-19 takes on the heart

Loss of smell in COVID-19 explained by scientists

COVID-19 could provide unintended glimpses into operation of complex Earth systems

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Unexpected neurologic complication identified in severe COVID-19

People with SARS-CoV-2 most infectious in days 0-5, no evidence of transmission after day 9

ONR helps develop low-cost ventilators to combat COVID-19

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

BMC joins Aspen Institute initiative to improve families’ health and economic prosperity

Non-White adults are more likely to worry about paying for COVID-19 treatment

COVID-19 may increase risk of blot cots in women who are pregnant or taking birth control pills

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News